VisusNano Ltd. is a privately held pre-clinical company founded in 2016, focusing on the development of a groundbreaking drug-eluting intraocular lens implant for cataract surgery. The company's innovation aims to enhance patient outcomes, eliminating the post-surgery requirement for eye drops and the need for YAG laser capsulotomy. This breakthrough has the potential to revolutionize cataract surgery, not only in the human market but also in the veterinary sector. Notably, the company recently secured Seed Round investment on 31 May 2024 from SOSV, showcasing confidence from prominent investors in the potential of VisusNano's cutting-edge technology. With its focus on Biotechnology and Health Care, VisusNano Ltd. is poised to make a significant impact in the field of ophthalmology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
31 May 2024 |
| Seed Round | Unknown | 1 |
|
23 Jan 2023 |
| Seed Round | Unknown | 2 |
|
02 Oct 2018 |
| Grant | £20.00K | 1 |
|
12 Jul 2018 |
| Seed Round | Unknown | 1 | Biostars | 01 Mar 2016 |
No recent news or press coverage available for VisusNano Ltd.
We care about your data, and we'd love to use cookies make your experience better.
